Methotrexate

BOSTON – In this video interview, Christy S. Harris, PharmD, BCOP, FHOPA, talked about poster sessions presented at Hematology/Oncology Pharmacy Association Annual Meeting.

BOSTON – Loriel J. Solodokin, PharmD, BCOP, talked about the “innovative research” presented at the poster sessions at Hematology/Oncology Pharmacy Association Annual Meeting in a video interview.

Exposure to TNF inhibitors nearly triples the risk for psoriasis among children with juvenile idiopathic arthritis, according to data published in the Annals of the Rheumatic Diseases.

Approximately 61% of patients with rheumatoid arthritis or psoriatic arthritis who use methotrexate report side effects following weekly dosing, including fatigue and nausea, according to data published in Rheumatology and Therapy.

A machine learning model combining pharmacogenomic biomarkers with baseline DAS28 joint count predicted methotrexate response in early rheumatoid arthritis, according to data published in Arthritis Care & Research.

Female sex was identified as a baseline predictor of increased odds of both nausea and alopecia in patients with rheumatoid arthritis beginning methotrexate treatment, according to data presented at ACR Convergence 2021.

In this video, Dana DiRenzo, MD, MHS, instructor of medicine at Johns Hopkins, discussed a session on the new ACR recommendations for managing patients with rheumatoid arthritis.

A number of approaches and therapies may be necessary to treat cutaneous dermatomyositis, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

While the 2021 American College of Rheumatology rheumatoid arthritis recommendations improved over the 2015 document, understanding the weaknesses and limitations of the most recent iteration can be beneficial, according to a presenter here.

Olokizumab is associated with significant improvements in rheumatoid arthritis signs, symptoms and physical function in patients with inadequate response to methotrexate, according to data published in the Annals of the Rheumatic Diseases.